Automated Antimicrobial Susceptibility Testing Market will grow at 8.9% CAGR, to be valued at US$ 2,554.9 Million by 2026 | Huge Growth Expected in Automated Antimicrobial Susceptibility Testing in Future

Global Automated Antimicrobial Susceptibility Testing Market

Global Automated Antimicrobial Susceptibility Testing Market, By Product Type (Instruments and Consumables), By Detection Method (Colorimetric and Turbidimetric), By Application (Antibacterial (Sepsis and Tuberculosis), Anti-viral, Antifungal, and Anti-parasitic), By End User (Diagnostic/Pathology Laboratories, Hospitals, Biotechnology, and Pharmaceutical Companies, and Contract Research Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), had a market valuation of US$ 1,295.5 million in 2018 and is estimated to grow at a CAGR of 8.9 percent during the forecast period (2018 - 2026).

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/2622

Drivers

The global automated antimicrobial susceptibility testing market is projected to expand due to increasing multidrug resistance studies, new product releases, and an increase in the number of the development programs and financing, among other factors. Antimicrobial susceptibility testing and multidrug resistivity measurement are used in a variety of research and development programs carried out by contract research organizations. Rising small molecule research and development by numerous manufacturing organizations is expected to boost AST acceptance during the forecast period. As per Cambrex Corporation's 2017 Small Molecules Survey, small molecules are expected to gain significant momentum in the healthcare industry, with the FDA's approval of 34 new small molecule companies in 2017.

To extend their product range, main players are releasing susceptibility monitoring systems in the market. Tedizolid susceptibility research was initiated by Thermo Fisher Scientific in March 2016, allowing microbiology laboratories to measure the susceptibility of meticulous and non-fastidious Gram-positive species that cause acute bacterial surface and tissue structure infections in adolescents.
“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2622

Growing the availability of such AST testing could lead to a rise in the use of susceptibility plates over the forecast period. In addition, bioMérieux released ETEST Ceftolozane/Tazobactam and ETEST Ceftazidime/Avibactam in 2017, which specifies the minimum inhibitory concentration (MIC) values needed to treat infections caused by multidrug-resistant species.

Browse 38 Market Data Tables and 25 Figures spread through 200 Pages and in-depth TOC on "Automated Antimicrobial Susceptibility Testing Market, By Product Type (Consumables and Instruments), By Detection Method (Colorimetric and Turbidimetric), By Application (Antibacterial (Sepsis and Tuberculosis), Anti-viral, Antifungal, and Anti-parasitic), By End User (Diagnostic/Pathology Laboratories, Hospitals, Biotechnology and Pharmaceutical Companies, and Contract Research Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

Over the forecast period, growing funding for research into antibiotic-resistant microbes is anticipated to fuel growth of the global automated antimicrobial susceptibility testing market. Symcel AB, a corporation that develops cell-based assay tools for real-time cell metabolism measurements, received US$ 4.23 million in Horizon 2020 funding in November 2017 to facilitate the company's assessment of enhanced antibiotic combination monitoring in sepsis patients.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/automated-antimicrobial-susceptibility-testing-market-to-surpass-us-25549-million-by-2026-1397

Key Takeaways

Due to increased R&D activities and demand for genomic and repertoire sequencing-based research, the global automated antimicrobial susceptibility testing market is expected to grow at a CAGR of 8.9% over the forecast period (2018–2026).

Due to an increase in product releases, the consumables market is projected to have the largest sales share in 2026. HiMedia Laboratories released the HiCrome Muller Hinton Agar product in 2016, which is used for presumed recognition and susceptibility research.

Key companies contributing to the global automated antimicrobial susceptibility testing market are Resistell AG, Creative Diagnostics, Dickinson and Company, Alifax Holding S.p.A., bioMérieux S.A., Bio-Rad Laboratories, Inc., HiMedia Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Becton, and Danaher Corporation.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/automated-antimicrobial-susceptibility-testing-market-2622

Table of Content

Global Automated Antimicrobial Susceptibility Testing Market Research Report
Section 1: Global Automated Antimicrobial Susceptibility Testing Industry Overview
Section 2: Global Economic Impact on Automated Antimicrobial Susceptibility Testing Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Automated Antimicrobial Susceptibility Testing Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Automated Antimicrobial Susceptibility Testing Market Forecast

Other Exclusive Reports:

Global Special Purpose Needles market analysis - https://www.medgadget.com/2021/08/special-purpose-needles-market-size-expected-to-reach-a-7-8-cagr-by-new-methods-advanced-technologies-top-company-profiles-industry-share-and-trends-analysis-to-2027.html

Global Compression Garments and Stockings market analysis - https://www.medgadget.com/2021/08/compression-garments-and-stockings-market-growth-with-healthy-cagr-of-5-1-to-reach-us-3541-1-million-till-2027-finds-coherent-market-insights.html

Global Transcatheter Heart Valve market analysis - https://www.medgadget.com/2021/08/transcatheter-heart-valve-market-2021-predominantly-boosted-with-cagr-of-14-1-by-the-rising-global-economy-cmi-revealing-industry-analysis-to-2027.html

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

This release was published on openPR.